Group 1 - The company announced the appointment of several non-executive directors, including Dr. Chang Zhao Hua, Mr. Bai Teng Tai Si, Mr. Lu Tian Nian, and Ms. Liang Min, effective from the end of the extraordinary general meeting [1] - Dr. Liu Guo En and Mr. Zhou Jia Hong have been appointed as independent non-executive directors, effective from the end of the extraordinary general meeting [1] - Dr. Chang Zhao Hua will further serve as the chairman of the board starting from November 25, 2025 [1] Group 2 - The composition of the board committees will change from November 25, 2025, with Mr. Zhou Jia Hong as the chairman of the Audit Committee [1] - The Remuneration and Assessment Committee will be chaired by Dr. Liu Guo En [1] - The Nomination Committee will be chaired by Mr. Yao Hai Song [1] - The Strategy and Development Committee will also be chaired by Dr. Liu Guo En [1] - The Commercialization Committee will be chaired by Mr. Bai Teng Tai Si [1] Group 3 - The board announced that Mr. Sun Hong Bin will no longer serve as the authorized representative of the company, with Dr. Chang Zhao Hua taking over this role effective from November 25, 2025 [2]